IBDEI015 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,944,0)
 ;;=611.1^^9^79^16
 ;;^UTILITY(U,$J,358.3,944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,944,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,944,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,944,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,945,0)
 ;;=704.1^^9^79^17
 ;;^UTILITY(U,$J,358.3,945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,945,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,945,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,945,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,946,0)
 ;;=251.2^^9^79^30
 ;;^UTILITY(U,$J,358.3,946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,946,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,946,1,5,0)
 ;;=5^Hypoglycemia NOS
 ;;^UTILITY(U,$J,358.3,946,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,947,0)
 ;;=253.2^^9^79^34
 ;;^UTILITY(U,$J,358.3,947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,947,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,947,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,947,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,948,0)
 ;;=733.00^^9^79^43
 ;;^UTILITY(U,$J,358.3,948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,948,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,948,1,5,0)
 ;;=5^Osteoporosis NOS
 ;;^UTILITY(U,$J,358.3,948,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,949,0)
 ;;=278.00^^9^79^40
 ;;^UTILITY(U,$J,358.3,949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,949,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,949,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,949,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,950,0)
 ;;=278.01^^9^79^39
 ;;^UTILITY(U,$J,358.3,950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,950,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,950,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,950,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,951,0)
 ;;=250.80^^9^79^10
 ;;^UTILITY(U,$J,358.3,951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,951,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,951,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,951,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,952,0)
 ;;=250.00^^9^79^5
 ;;^UTILITY(U,$J,358.3,952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,952,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,952,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,952,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,953,0)
 ;;=250.40^^9^79^6
 ;;^UTILITY(U,$J,358.3,953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,953,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,953,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,953,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,954,0)
 ;;=250.50^^9^79^9
 ;;^UTILITY(U,$J,358.3,954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,954,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,954,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,954,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,955,0)
 ;;=250.60^^9^79^7
 ;;^UTILITY(U,$J,358.3,955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,955,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,955,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,955,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,956,0)
 ;;=250.70^^9^79^8
 ;;^UTILITY(U,$J,358.3,956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,956,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,956,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,956,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,957,0)
 ;;=250.01^^9^79^4
 ;;^UTILITY(U,$J,358.3,957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,957,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,957,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,957,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,958,0)
 ;;=272.0^^9^79^22
 ;;^UTILITY(U,$J,358.3,958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,958,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,958,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,958,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,959,0)
 ;;=272.1^^9^79^28
 ;;^UTILITY(U,$J,358.3,959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,959,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,959,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,959,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,960,0)
 ;;=272.2^^9^79^24
 ;;^UTILITY(U,$J,358.3,960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,960,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,960,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,960,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,961,0)
 ;;=275.42^^9^79^21
 ;;^UTILITY(U,$J,358.3,961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,961,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,961,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,961,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,962,0)
 ;;=275.41^^9^79^29
 ;;^UTILITY(U,$J,358.3,962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,962,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,962,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,962,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,963,0)
 ;;=276.7^^9^79^23
 ;;^UTILITY(U,$J,358.3,963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,963,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,963,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,963,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,964,0)
 ;;=275.2^^9^79^19
 ;;^UTILITY(U,$J,358.3,964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,964,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,964,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,964,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,965,0)
 ;;=276.0^^9^79^25
 ;;^UTILITY(U,$J,358.3,965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,965,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,965,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,965,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,966,0)
 ;;=276.1^^9^79^32
 ;;^UTILITY(U,$J,358.3,966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,966,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,966,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,966,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,967,0)
 ;;=275.3^^9^79^20
 ;;^UTILITY(U,$J,358.3,967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,967,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,967,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,967,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,968,0)
 ;;=240.0^^9^79^14
 ;;^UTILITY(U,$J,358.3,968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,968,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,968,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,968,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,969,0)
 ;;=241.1^^9^79^13
 ;;^UTILITY(U,$J,358.3,969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,969,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,969,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,969,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,970,0)
 ;;=241.0^^9^79^50
 ;;^UTILITY(U,$J,358.3,970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,970,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,970,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,970,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,971,0)
 ;;=242.00^^9^79^15
 ;;^UTILITY(U,$J,358.3,971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,971,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,971,1,5,0)
 ;;=5^Graves' Disease
 ;;^UTILITY(U,$J,358.3,971,2)
 ;;=^267793
 ;;^UTILITY(U,$J,358.3,972,0)
 ;;=242.01^^9^79^12
 ;;^UTILITY(U,$J,358.3,972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,972,1,4,0)
 ;;=4^242.01
 ;;^UTILITY(U,$J,358.3,972,1,5,0)
 ;;=5^Goiter Diff Tox W Strm
 ;;^UTILITY(U,$J,358.3,972,2)
 ;;=^267794
 ;;^UTILITY(U,$J,358.3,973,0)
 ;;=252.1^^9^79^33
 ;;^UTILITY(U,$J,358.3,973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,973,1,4,0)
 ;;=4^252.1
 ;;^UTILITY(U,$J,358.3,973,1,5,0)
 ;;=5^Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,973,2)
 ;;=^60635
 ;;^UTILITY(U,$J,358.3,974,0)
 ;;=242.90^^9^79^27
 ;;^UTILITY(U,$J,358.3,974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,974,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,974,1,5,0)
 ;;=5^Hyperthyroidism w/o Goiter/Storm
 ;;^UTILITY(U,$J,358.3,974,2)
 ;;=^267811
 ;;^UTILITY(U,$J,358.3,975,0)
 ;;=242.91^^9^79^26
 ;;^UTILITY(U,$J,358.3,975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,975,1,4,0)
 ;;=4^242.91
 ;;^UTILITY(U,$J,358.3,975,1,5,0)
 ;;=5^Hyperthyroidism w/o Goit w/ Storm
 ;;^UTILITY(U,$J,358.3,975,2)
 ;;=^267812
 ;;^UTILITY(U,$J,358.3,976,0)
 ;;=244.0^^9^79^36
 ;;^UTILITY(U,$J,358.3,976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,976,1,4,0)
 ;;=4^244.0
 ;;^UTILITY(U,$J,358.3,976,1,5,0)
 ;;=5^Hypothyroid, Postsurgical
 ;;^UTILITY(U,$J,358.3,976,2)
 ;;=^267814
 ;;^UTILITY(U,$J,358.3,977,0)
 ;;=244.2^^9^79^35
 ;;^UTILITY(U,$J,358.3,977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,977,1,4,0)
 ;;=4^244.2
 ;;^UTILITY(U,$J,358.3,977,1,5,0)
 ;;=5^Hypothyroid d/t Iodine Rx
 ;;^UTILITY(U,$J,358.3,977,2)
 ;;=^267817
 ;;^UTILITY(U,$J,358.3,978,0)
 ;;=244.9^^9^79^37
 ;;^UTILITY(U,$J,358.3,978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,978,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,978,1,5,0)
 ;;=5^Hypothyroid, Unspec Cause
 ;;^UTILITY(U,$J,358.3,978,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,979,0)
 ;;=245.0^^9^79^51
 ;;^UTILITY(U,$J,358.3,979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,979,1,4,0)
 ;;=4^245.0
 ;;^UTILITY(U,$J,358.3,979,1,5,0)
 ;;=5^Thyroiditis, Acute
 ;;^UTILITY(U,$J,358.3,979,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,980,0)
 ;;=245.1^^9^79^52
 ;;^UTILITY(U,$J,358.3,980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,980,1,4,0)
 ;;=4^245.1
 ;;^UTILITY(U,$J,358.3,980,1,5,0)
 ;;=5^Thyroiditis, Subacute
 ;;^UTILITY(U,$J,358.3,980,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,981,0)
 ;;=733.01^^9^79^45
 ;;^UTILITY(U,$J,358.3,981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,981,1,4,0)
 ;;=4^733.01
 ;;^UTILITY(U,$J,358.3,981,1,5,0)
 ;;=5^Osteoporosis, Senile
 ;;^UTILITY(U,$J,358.3,981,2)
 ;;=Osteoporosis, Senile^87188
 ;;^UTILITY(U,$J,358.3,982,0)
 ;;=733.02^^9^79^44
 ;;^UTILITY(U,$J,358.3,982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,982,1,4,0)
 ;;=4^733.02
 ;;^UTILITY(U,$J,358.3,982,1,5,0)
 ;;=5^Osteoporosis, Idiopathic
